Editorial: RNA recognition landscapes and anticancer drug targeting.

Salvati, Erica; Lewinska, Anna; Dassi, Erik; Wnuk, Maciej; D'Agostino, Vito G

Salvati, Erica; Lewinska, Anna; Dassi, Erik; Wnuk, Maciej; D'Agostino, Vito G.

Afiliación

Salvati E; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
Lewinska A; Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Rzeszow, Poland.
Dassi E; Laboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Wnuk M; Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Rzeszow, Poland.
D'Agostino VG; Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

Front Oncol ; 13: 1222883, 2023.

Article en En | MEDLINE | ID: mdl-37404766

Palabras clave

RNA; RNA-binding proteins; anti-cancer; anti-inflammatory; drug; mechanism of action (MOA); post-transcriptional control

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google